Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace

NCT ID: NCT07078786

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-13

Study Completion Date

2025-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As baby grows inside the womb of mother, heart and other organs develop. The heart activity can be recorded by placing a transducer on the belly of mother. The tracing obtain provides information about heart rate, any increase or decrease in heart rate and how much it varies with time. Variation in heart rate along with increase is indicator of fetal well being. Some mothers are at high risk of pre-term birth that is baby delivery before 37 weeks of gestation. In such cases steroids are given to mother to accelerate lung development of the baby so that it can easily adapt to outside world. Dexamethasone and Betamethasone are commonly used steroids which can also effect fetal heart activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Some patients are at high risk of Pre term birth and therefore they are advised antenatal steroids which facilitates fetal lung development preparing it for smoother transition for extra-uterine life. Dexamethasone and Betamethasone are commonly used for this purpose but differently effect fetal cardiac activity as evident by CTG changes and awareness of these phenomena would prevent iatrogenic delivery of preterm fetuses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiotocography Steroids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participants will be randomly divided into two groups using computer generated numbers and will be masked to the treatment they receive. The person assessing outcome i.e. fetal cardiotography activity will be masked to the treatment participant received.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group Betamethasone

Intramuscular injection of Betamethasone 12mg will be administered on 2 consecutive days

Group Type EXPERIMENTAL

Betamethason Sodium Phosphate

Intervention Type DRUG

Intramuscular injection of Betamethasone 12mg will be administered on 2 consecutive days

Group Dexmaethasone

24mg of Dexamethasone in two divided doses will be given Intramuscularly over 24 hours apart

Group Type ACTIVE_COMPARATOR

Dexamethasone

Intervention Type DRUG

two doses of 12mg of IM Dexamethasone given 24 hours apart

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Betamethason Sodium Phosphate

Intramuscular injection of Betamethasone 12mg will be administered on 2 consecutive days

Intervention Type DRUG

Dexamethasone

two doses of 12mg of IM Dexamethasone given 24 hours apart

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* History of pre term labor
* Preterm pre labor rupture of membranes
* Third trimester bleeding due to placenta previa

Exclusion Criteria

* IUGR
* Uteroplacental insufficiency
* Oligohydroamnios
* Maternal drug therapy that can effect fetal heart rate
* Contraindications to Intramuscular injections
* Patients admitted with non reassuring CTG
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rawalpindi Medical College, Pakistan

OTHER

Sponsor Role collaborator

Rawalpindi Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ifra Shafique

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ifra Shafique, MBBS

Role: PRINCIPAL_INVESTIGATOR

Rawalpindi Medical Unviersity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Holy Family Hospital, Rawalpindi Medical University

Rawalpindi, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ifra Shafique, MBBS

Role: CONTACT

+92-3039007053

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tallat Farkhanda, MBBS,FCPS

Role: primary

+92-323-5112728

References

Explore related publications, articles, or registry entries linked to this study.

Rotmensch S, Liberati M, Vishne TH, Celentano C, Ben-Rafael Z, Bellati U. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstet Gynecol Scand. 1999 Jul;78(6):493-500.

Reference Type BACKGROUND
PMID: 10376858 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1080/IREF/RMU/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fetal Cardiac Function
NCT06381258 COMPLETED
Cardiac Output in Preeclamptic
NCT05435573 UNKNOWN NA